Taken together, our studies revealed the mechanism by which TRAF6 exerts its role in NSCLC development and suggested TRAF6 maybe was a promising candidate target for lung cancer prevention and therapy. This evidence concerns the gene TRAF6 and non-small cell lung carcinoma.